REGENERON PHARMACEUTICALS
REGNNASDAQ$748.47▼ $3.74 (−0.50%)
LiveTrack REGN
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 6.9%
14d▼ 3.3%
30d▼ 5.7%
ytd▼ 3.0%
1y▲ 33.5%
🏦Market Cap
$77.11B
Mid Cap
📈Revenue Growth (YoY)
+1.0%
Slowing
📊Gross Margin
84.9%
High
💵FCF Margin
22.7%
Strong
⚖️P/S Ratio
5.0x
Fair
Otter Score
72
Fair
Earnings
Q2 · 2026Reported 2026-06-30Earnings Per Share
Actual
14.29
Expected
10.47
beat
+36.50%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
14.29
beat
Q1 2026
9.47
beat
Q4 2025
11.44
beat
Q3 2025
11.83
beat